Connect with us


New FDA Approved Robot Assistant: A Step Closer To A Robotic Future!



Robot Assistant

Last month, US Food and Drug administration marked a historic move by introducing robot assistant in the field of medicine which requires extreme precision and extensive care. It has approved the utilization of a robot surgeon for minimally-invasive surgeries.

Letting robots to interfere our lives may sound a bit alarming to many. But, making  Senhance, to be a part of surgical procedures is much more frightening.

Fourth Industrial Revolution: Robots Assistance In All Fields

Robot Assistant

Recent development in the world of robotics has made them more user-friendly, intelligent and, most importantly, affordable than ever before. From industrial manufacturing to the medical field, it is no wonder that robots are substantially transforming our lives. The first industrial robot was developed in the USA in 1960. Since its introduction, the technology behind robots is continuously improving and immensely creating many advantages for humans. Robots are becoming widespread in various industries. This technology revolution has obvious implications to increase productivity and safety, along with saving the time and money.

Robots have not just landed in our workplace. You can trace its roots back in 1960. Today this fourth industrial revolution is expanding skills, moving up the corporate ladder by showing awesome productivity and increasingly shoving aside their human counterpart in society. The exponential growth of robots is bringing incredible precision, productivity as well as flexibility. Additionally, there is a boom in collaborative robots that can seamlessly work hand in hand with human workers.

Our robot ridden future is surrounded by much negativity. Sensationalists fear that ruthless robotic appropriation spreading like a wildfire will undertake thousands or millions of jobs. But the recent advancement of intelligent machines is not miserable. The high IoT products making waves today will save lives in the near future.

Senhance, A Robot Assistant Surgical Device

Senhance is a Robot Assistant Surgical Device (RASD), designed and developed by a medical device company TransEnterix. This device lets the surgeon make use of the software and computer technology to move and control surgical instruments. Moreover this device is useful in procedures which involve one or more tiny incisions in the body of the patient. The surgeon can operate Senhance with the help of a console unit or cockpit with 3D high definition view of the surgical field. It allows surgeons to control three separate arms equipped with surgical instruments remotely.

RASD technology, first innovation in minimally invasive surgery is designed with an objective to enhance access and visualization within confined operative sites for the surgeon. The inclusion of force feedback, which allows surgeons to feel the tissue that they are grasping with robotic arm is something which is making Senhance more interesting. It seems like your doctor has three additional extremely dexterous arms. It also boosts eye tracking to control the movement of surgical instruments.

Man And Machine Interaction

Due to ineluctable robot oppression, it is easy to assume that there would be conflict in robot-human work dynamics instead of significant mutual beneficence. Senhance based robotic surgery has potential to increase the survival rate of infamously dangerous operations. The approval and clearance of Senhance in the US is a milestone in the progress of robots. It will also deliver improvement in efficacy, value, and choices available to a patient, surgeon, and hospitals.

Robotic surgery, the use of a Robot Assisstant in medical procedures, is not a new concept. Certainly, the technology behind it was continuously evolving over the past couple of years. The purpose of devising Senhance is to improve precision and safety during the procedures. It assists the surgeons not to take away their control over a procedure. Still, there is always some human intervention behind any system.

In the US, millions of millions of surgical procedures take place with the basic manual tools. All these tools limit the capability, comfort, and control of the surgeons. Hence, there is a need for new choices that can enhance the sense, power, and support of the surgeon. For a patient, these tools will minimize the invasiveness, and for hospitals, it will maximize value. Senhance, a Robot Assistant in medicine, is one of those new choices.

See also: The New Bio-Threat Detection Ring – Another Hint Towards A Dystopian Future of Wearables

Continue Reading


Novuson’s Ultrasonic Surgical Device Built For Bloodless Surgeries



Bloodless Surgeries

Novuson Surgical’s patented Ultrasound surgical tool technology allows the practitioner for automated, precise, rapid, and bloodless surgeries. Their technology dramatically decreases surgery times, raises patient outcomes, and makes significant cost savings for the healthcare scheme.

Traditional means of controlling bleeding during surgeries require 45-60 minutes of work by an extremely specialized practitioner. Surgeons cut, clamp and suture in a race against blood loss.

With Novuson technology, multiple methods that earlier took 40-60 minutes of highly specialized care. But now can be performed in almost 3 minutes, in a fully automated bloodless surgeries that cause no more damage to healthy tissue.

Novuson’s Ultrasonic Surgical Device will be the first and alone technology intelligent enough to provide precise, rapid ablation of thick tissues. No clue exists currently for the prompt and accurate ablation of soft tissues of thicknesses larger than 5mm.

By producing a focused level of ultrasound energy from the effective surface of surgical clamps, Novuson sears tissue in a specifically controlled plane within the clamp faces.

The ultrasonic energy ablates the tissue from the inside out, exactly where the surgeon intends. It eliminates the risk of damaging other muscles. Their automated technology applies just enough therapy to control bleeding entirely and stops automatically when the procedure is finished.

The Novuson system is combined with the working surfaces of a surgical clamp. When treating a whole section at once, the device uses energy to ablates the tissue and automatically ends when the therapy is completed.

The device hooks in and holds itself till the time-period of the procedure with an average time of 3 minutes. The device monitors completion of the operation in real time.

Novuson device cleans the tissue precisely only where required with pinpoint precision of 1mm. It is done to the tissue’s side till it is entirely cured.

The Ablation of tissues from inside out prevents heating of the clamps surfaces. And eliminates the risk of adhering the tissue or producing smoke (as other ablation tools do).

Patients are left with the identical scars as formed after the stitches. Except this their cauterization appears more rapidly and uniformly. Patients will experience faster healing and minimizes the chances reoperation with complete bleeding control during the procedure.

Patients will experience faster healing and minimizes the chances reoperation with complete bleeding control during the procedure.

How Novuson Bloodless Surgeries Benefits To Hospital

With single Novuson unit, it will save a hospital $1.2m or more in one year.

  • Shorter procedure times
  • Lower risk for failure
  • Decreased blood product usage
  • Minimizes the use of anesthesia
  • Faster recovery chances
  • Improved surgical results.

By Combining positive economic outcome for the hospitals with a dramatically improved workflow practice for surgeons.

Novuson is well placed to disrupt developing and significant surgical markets motivated by the sign of bloodless surgery.

Novuson produces meaningful cost savings to hospitals. It extends access to care and significantly advances reliable outcomes.

Continue Reading